Correction: Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome

Patricia S.P. Thong; Kijoon Lee; Hui-Jin Toh; Jing Dong; Chuan-Sia Tee; Kar-Perng Low; Pui-Haan Chang; Ramaswamy Bhuvaneswari; Ngian-Chye Tan; Khee-Chee Soo

doi:10.18632/oncotarget.26742

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome

PDF | How to cite

Oncotarget. 2019; 10:1602-1602. https://doi.org/10.18632/oncotarget.26742

Metrics: PDF 1225 views | ?

Patricia S.P. Thong¹, Kijoon Lee^2,4,6, Hui-Jin Toh¹, Jing Dong^2,4,5, Chuan-Sia Tee¹, Kar-Perng Low¹, Pui-Haan Chang¹, Ramaswamy Bhuvaneswari¹, Ngian-Chye Tan³ and Khee-Chee Soo¹

¹ Division of Medical Sciences, National Cancer Centre, Singapore
² Division of Bioengineering, School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore
³ Division of Surgical Oncology, National Cancer Centre, Singapore
⁴ Nanyang Technological University, Singapore
⁵ Current address: Harvard Medical School and Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, USA
⁶ Current address: Daegu Gyeongbuk Institute of Science and Technology, Daegu, Korea

Published: February 22, 2019

This article has been corrected: The correct author name is given below:

Patricia S.P. Thong

Original article: Oncotarget. 2017; 8:19902-19913. DOI: https://doi.org/10.18632/oncotarget.15720.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26742

Publication Alerts

Corrections:

Correction: Early assessment of tumor response to photodynamic therapy using combined diffuse optical and diffuse correlation spectroscopy to predict treatment outcome